|
by Peprah, Kwakye, MacDougall, Danielle
Published 2019
“...The objective of this report is to summarize the evidence regarding the clinical effectiveness...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, McCormack, Suzanne
Published 2020
“... nausea or vomiting. An additional objective is to synthesize evidence on the comparative clinical...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, Argáez, Charlene
Published 2020
“... of physical activity on chronic non-cancer pain. Therefore, the objective of this report is to review...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, McCormack, Suzanne
Published 2020
“... nausea or vomiting. An additional objective is to synthesize evidence on the comparative clinical...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, Argáez, Charlene
Published 2020
“... of physical activity on chronic non-cancer pain. Therefore, the objective of this report is to review...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, McCormack, Suzanne
Published 2019
“... and disparate evidence. The objective of this report is to summarize the evidence regarding the clinical...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, Severn, Melissa, Wells, Charlotte, Subramonian, Anusree
Published 2020
“... sedation during ERCP. An additional objective is to synthesize evidence-based guidelines for moderate...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, McCormack, Suzanne
Published 2019
“... and disparate evidence. The objective of this report is to summarize the evidence regarding the clinical...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, Severn, Melissa, Wells, Charlotte, Subramonian, Anusree
Published 2020
“... sedation during ERCP. An additional objective is to synthesize evidence-based guidelines for moderate...”Published 2020
Canadian Agency for Drugs and Technologies in Health